These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 1342678

  • 1. [Potential value of 5-HT2 receptor antagonists in the treatment of dysthymic disorders].
    Sechter D, Bonin B, Bizouard P.
    Encephale; 1992 Dec; 18 Spec No 5():753-4. PubMed ID: 1342678
    [No Abstract] [Full Text] [Related]

  • 2. Serotonin receptor subtypes: implications for psychopharmacology.
    Cowen PJ.
    Br J Psychiatry Suppl; 1991 Sep; (12):7-14. PubMed ID: 1840764
    [Abstract] [Full Text] [Related]

  • 3. The marketing of 5-hydroxytryptamine: depression or anxiety?
    Healy D.
    Br J Psychiatry; 1991 Jun; 158():737-42. PubMed ID: 1873625
    [No Abstract] [Full Text] [Related]

  • 4. [Central serotonin receptors. Principal fundamental and functional aspects. Therapeutic applications].
    Moulignier A.
    Rev Neurol (Paris); 1994 Jun; 150(1):3-15. PubMed ID: 7801037
    [Abstract] [Full Text] [Related]

  • 5. The clinical utility of pharmacological agents that act at serotonin receptors.
    Peroutka SJ, Sleight AJ, McCarthy BG, Pierce PA, Schmidt AW, Hekmatpanah CR.
    J Neuropsychiatry Clin Neurosci; 1989 Jun; 1(3):253-62. PubMed ID: 2562495
    [Abstract] [Full Text] [Related]

  • 6. Is there action beyond receptors?
    Hrdina PD.
    J Psychiatry Neurosci; 1993 Mar; 18(2):57-9. PubMed ID: 8384874
    [No Abstract] [Full Text] [Related]

  • 7. Serotonin: a common neurobiologic substrate in anxiety and depression.
    Eison MS.
    J Clin Psychopharmacol; 1990 Jun; 10(3 Suppl):26S-30S. PubMed ID: 2198299
    [Abstract] [Full Text] [Related]

  • 8. Serotonin dysfunction syndromes: a functional common denominator for classification of depression, anxiety, and obsessive-compulsive disorder.
    Benkert O, Wetzel H, Szegedi A.
    Int Clin Psychopharmacol; 1993 Sep; 8 Suppl 1():3-14. PubMed ID: 8254151
    [No Abstract] [Full Text] [Related]

  • 9. Serotonin-specific drugs for anxiety and depressive disorders.
    Charney DS, Krystal JH, Delgado PL, Heninger GR.
    Annu Rev Med; 1990 Sep; 41():437-46. PubMed ID: 2139556
    [Abstract] [Full Text] [Related]

  • 10. Behavioral pharmacology: potential antidepressant and anxiolytic properties.
    Wesołowska A, Jastrzębska-Więsek M.
    Int Rev Neurobiol; 2011 Sep; 96():49-71. PubMed ID: 21329784
    [No Abstract] [Full Text] [Related]

  • 11. Mixed depression and anxiety: serotonin1A receptors as a common pharmacologic link.
    Stahl SM.
    J Clin Psychiatry; 1997 Sep; 58 Suppl 8():20-6. PubMed ID: 9236732
    [Abstract] [Full Text] [Related]

  • 12. Drug treatment of anxiety and depression.
    Fox T.
    Practitioner; 1991 Sep; 235(1506):681-3. PubMed ID: 1796034
    [No Abstract] [Full Text] [Related]

  • 13. [Mechanism of action, indications and abuse of benzodiazepine anxiolytic drugs].
    Goffinet S.
    Ann Med Psychol (Paris); 1993 Jan; 151(1):47-63. PubMed ID: 7905724
    [Abstract] [Full Text] [Related]

  • 14. Pharmacologic modification of serotonergic function: drugs for the study and treatment of psychiatric and other disorders.
    Fuller RW.
    J Clin Psychiatry; 1986 Apr; 47 Suppl():4-8. PubMed ID: 3514585
    [Abstract] [Full Text] [Related]

  • 15. Serotonin selectivity for obsessive compulsive and panic disorders.
    Montgomery SA, Bullock T, Fineberg N.
    J Psychiatry Neurosci; 1991 Jul; 16(2 Suppl 1):30-5. PubMed ID: 1931935
    [No Abstract] [Full Text] [Related]

  • 16. 5-HT2 receptor antagonism in dysthymic disorder: a double-blind placebo-controlled study with ritanserin.
    Bersani G, Pozzi F, Marini S, Grispini A, Pasini A, Ciani N.
    Acta Psychiatr Scand; 1991 Apr; 83(4):244-8. PubMed ID: 1903019
    [Abstract] [Full Text] [Related]

  • 17. [New directions in GABAergic pharmacology of anxiety and depression].
    Kaluev AV, Nutt DD.
    Eksp Klin Farmakol; 2004 Apr; 67(6):3-7. PubMed ID: 15707004
    [Abstract] [Full Text] [Related]

  • 18. Role of serotonin in therapy of depression and related disorders.
    Fuller RW.
    J Clin Psychiatry; 1991 May; 52 Suppl():52-7. PubMed ID: 1674251
    [Abstract] [Full Text] [Related]

  • 19. Panic disorder: the potential role of serotonin reuptake inhibitors.
    Sheehan DV, Zak JP, Miller JA, Fanous BS.
    J Clin Psychiatry; 1988 Aug; 49 Suppl():30-6. PubMed ID: 3045109
    [Abstract] [Full Text] [Related]

  • 20. 5-HT7, neurogenesis and antidepressants: a promising therapeutic axis for treating depression.
    Nandam LS, Jhaveri D, Bartlett P.
    Clin Exp Pharmacol Physiol; 2007 Aug; 34(5-6):546-51. PubMed ID: 17439430
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.